English

Remibrutinib

Remibrutinib Featured Image
  • Remibrutinib

Short Description:

API’s Name CAS No. US DMF EU DMF Patent Expiry Date( U.S)
Remibrutinib 920509-32-6  2027   Nov.13, 2034

 

[Indication] 

  • Chronic spontaneous urticaria (CSU): For the treatment of chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamine treatment.


Product Detail

Product Tags

  • Previous:
  • Next:
    • Write your message here and send it to us

    Products categories